Corrigendum to "Mild cognitive impairment due to Alzheimer disease: Contemporary approaches to diagnostics and pharmacological intervention" [Pharmacol. Res. 129 (2018) 216-226]
Pharmacol Res. 2018 Jun:132:245.
doi: 10.1016/j.phrs.2018.03.006.
Epub 2018 Mar 17.
1 Institute of Physiologically Active Compounds of the RussianAcademy of Sciences, Severniy Proezd, Chernogolovka, Moscow Region, 1142432, Russia. Electronic address: bachurin@ipac.ac.ru.
2 Mental Health Research Center, 34 Kashirskoyeshosse, Moscow, 115522, Russia.
3 Institute of Physiologically Active Compounds of the RussianAcademy of Sciences, Severniy Proezd, Chernogolovka, Moscow Region, 1142432, Russia.
4 Departamento de Nutrición y Bioquímica, Facultad de Ciencias, Pontificia Universidad Javeriana, Bogotá D.C., Colombia; Instituto de Ciencias Biomédicas, Universidad Autónoma de Chile, Santiago, Chile.
5 Institute of Physiologically Active Compounds of the RussianAcademy of Sciences, Severniy Proezd, Chernogolovka, Moscow Region, 1142432, Russia; GALLY International Biomedical Research Consulting LLC., San Antonio, TX 78229, USA; School of Health Science and Healthcare Administration, University of Atlanta, Johns Creek, GA 30097, USA. Electronic address: aliev03@gmail.com.